Faculty of Pharmacy, Pharmaceutics Department, El Saleheya El Gadida University, El Saleheya El Gadida, 44813, Egypt.
Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Curr Drug Metab. 2022;23(4):329-338. doi: 10.2174/1389200223666220321111214.
Aceclofenac is a non-steroidal anti-inflammatory drug and a potent analgesic. However, its oral ingestion may cause gastrointestinal problems, including dyspepsia, abnormal pain, nausea, diarrhea, and ulcerative colitis.
This study aimed to prepare vesicular-based enteric microspheres containing aceclofenac by ionotropic gelation technique to minimize gastric irritation in rats.
The micron-size vesicles were prepared by the ionic-orifice gelation method. Three types of vesicularbased microcapsules containing aceclofenac were prepared by employing sodium alginate as the coating material in combination with Eudragit L100, Eudragit S100, and polyvinylpyrrolidone PVP K90. The drug to sodium alginate to polymer ratios were 1:0.5:0.5, 1:1:1, and 1:1.5:1.5, respectively. Gelation of sodium alginate was induced by the dropwise addition of calcium chloride solution (10 % w/v). Aceclofenac-loaded microspheres were evaluated in terms of aceclofenac content and in vitro drug release, and FTIR, DSC, and XRD were used for physicochemical evaluation of some selected formulae. The effects of microencapsulation on aceclofenac-induced ulcerative activity in male Wistar rats were also investigated.
The results indicated no interaction between aceclofenac and microcapsules forming polymers. In addition, microcapsules formulations M1, M4, and M7 gave maximal protection in acidic pH and optimal release in alkaline pH. The histopathological studies revealed that the reduction of ulceration is evident from the macroscopic and microscopic studies, which showed complete protection of the tissue morphology with no ulcers, indicating the effectiveness of the microcapsules system against aceclofenac-induced gastric ulceration in rats again.
Ionotropic gelation seems to be a simple, efficient technique to prepare aceclofenac-loaded microspheres with a reduced risk of gastric ulceration. It is possible to overcome the problem of gastric damage while utilizing aceclofenac by avoiding the exposure of the drug to the ulcer-prone area of the gastrointestinal tract.
醋氯芬酸是非甾体抗炎药和强效镇痛药。然而,其口服摄入可能会导致胃肠道问题,包括消化不良、异常疼痛、恶心、腹泻和溃疡性结肠炎。
本研究旨在通过离子凝胶技术制备载醋氯芬酸的囊泡型肠溶微球,以最小化大鼠的胃刺激。
采用离子孔凝胶法制备微米级囊泡。采用海藻酸钠作为包衣材料,分别与 Eudragit L100、Eudragit S100 和聚维酮 PVP K90 结合,制备三种载醋氯芬酸的囊泡型微囊。药物与海藻酸钠与聚合物的比例分别为 1:0.5:0.5、1:1:1 和 1:1.5:1.5。海藻酸钠的凝胶化是通过滴加氯化钙溶液(10%w/v)诱导的。通过测定载药微球的载药量和体外药物释放度来评价载药微球,并用傅里叶变换红外光谱(FTIR)、差示扫描量热法(DSC)和 X 射线衍射(XRD)对部分选定配方进行物理化学评价。还研究了微囊化对雄性 Wistar 大鼠醋氯芬酸诱导溃疡性活动的影响。
结果表明,醋氯芬酸与形成聚合物的微胶囊之间没有相互作用。此外,微囊制剂 M1、M4 和 M7 在酸性 pH 下提供最大保护,在碱性 pH 下提供最佳释放。组织病理学研究表明,从宏观和微观研究中可以明显看出溃疡的减少,组织形态学完全得到保护,没有溃疡,表明微囊系统对大鼠醋氯芬酸诱导的胃溃疡具有有效性。
离子凝胶似乎是一种简单、高效的技术,可制备载醋氯芬酸的微球,降低胃溃疡的风险。通过避免药物暴露在胃肠道易患溃疡的区域,可以克服胃损伤的问题,同时利用醋氯芬酸。